TGFB1 and neoplasm: Furthermore, the binding of soluble PS released by tumor cells to the PS receptor (PSR) has been shown to result in the production of anti-inflammatory mediators that block antitumor immune responses [e.g., tumor growth factor (TGF)-β, interleukin (IL)-10 and prostaglandin E2 (PGE2)] [46].